Accuray | ARAY - Selling And Administration Expenses

Stock Price
0.37
Daily Change
-0.05 -11.88%
Monthly
-27.19%
Yearly
-79.78%
Q1 Forecast
0.36

Accuray reported $127.32M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Accuray USD 127.32M 500.16M Sep/2025
AngioDynamics USD 35.99M 14K Feb/2025
Artivion USD 50.02M 697K Sep/2024
AtriCure USD 78.34M 109K Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Inogen USD 43.77M 510K Jun/2024
Mesa Laboratories USD 27.31M 380K Sep/2024
Orthofix International USD 112.21M 1.1M Sep/2024
Surmodics USD 14.58M 2.05M Sep/2024
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Trinity Biotech USD 6.19M 2.18M Sep/2025